Although the TLR9 agonist CpG seemed quitepromising, being a strong Th1 adjuvant, clinical studies showed that vaccinescontaining CpG cause a severe autoimmune disease, Wegener’s granulomatosis [20]. Here, TLR9 is linked to granulomatosis with polyangiitis.